High-dose atorvastatin following ACS reduces risk of long-term adverse cardiovascular outcomes

被引：0
|
作者：
不详
机构：
来源：
FORMULARY | 2004年 / 39卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：198 / 198
页数：1
相关论文
共 50 条
  • [1] High-dose atorvastatin reduces the risk of cardiovascular events in patients with percutaneous coronary intervention
    Lu, Changqing
    Jia, Helei
    Wang, Zhentao
    [J]. ONCOTARGET, 2017, 8 (41) : 70356 - 70365
  • [2] Long-term safety and efficacy of high-dose Atorvastatin treatment in patients with familial hypercholesterolemia
    van Wissen, S
    Smilde, TJ
    Trip, MD
    Stalenhoef, AFH
    Kastelein, JJP
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2005, 95 (02): : 264 - 266
  • [3] DOSE-DEPENDENT EFFECT OF ATORVASTATIN ON LONG-TERM KIDNEY FUNCTION AND ASSOCIATED CARDIOVASCULAR OUTCOMES
    Vogt, L.
    Bangalore, S.
    Fayyad, R.
    Laskey, R.
    Hovingh, G. K.
    DeMicco, D. A.
    Waters, D.
    [J]. ATHEROSCLEROSIS, 2015, 241 (01) : E9 - E9
  • [4] Predictors of long-term outcome following high-dose chemotherapy in high-risk primary breast cancer
    Somlo, G
    Simpson, JF
    Frankel, P
    Chow, W
    Leong, L
    Margolin, K
    Morgan, R
    Raschko, J
    Shibata, S
    Forman, S
    Kogut, N
    McNamara, M
    Molina, A
    Somlo, E
    Doroshow, JH
    [J]. BRITISH JOURNAL OF CANCER, 2002, 87 (03) : 281 - 288
  • [5] Glaucoma risk increased a with long-term, high-dose inhaled corticosteroids
    不详
    [J]. GERIATRICS, 1997, 52 (06) : 20 - 20
  • [6] Predictors of long-term outcome following high-dose chemotherapy in high-risk primary breast cancer
    G Somlo
    J F Simpson
    P Frankel
    W Chow
    L Leong
    K Margolin
    R Morgan
    J Raschko
    S Shibata
    S Forman
    N Kogut
    M McNamara
    A Molina
    E Somlo
    J H Doroshow
    [J]. British Journal of Cancer, 2002, 87 : 281 - 288
  • [7] HIGH-DOSE AND LONG-TERM USE OF ONDANSETRON
    VOHRA, S
    JURICIC, J
    [J]. ANNALS OF PHARMACOTHERAPY, 1992, 26 (01) : 128 - 129
  • [8] High-dose atorvastatin attenuates cardiovascular risk prediction of the metabolic syndrome components
    Deedwania, Prakash
    Grundy, Scott M.
    Kastelein, John J.
    Breazna, Andrei
    [J]. CIRCULATION, 2007, 116 (16) : 847 - 848
  • [9] ADVERSE-EFFECTS AND SAFETY OF LONG-TERM HIGH-DOSE AMOXICILLIN IN PATIENTS WITH BRONCHIECTASIS
    CURRIE, DC
    YAKUBU, Y
    CHADWICK, MV
    GAYA, H
    COLE, PJ
    [J]. THORAX, 1987, 42 (03) : 234 - 234
  • [10] HYPERVITAMINOSIS A FOLLOWING LONG-TERM USE OF HIGH-DOSE FISH OIL SUPPLEMENTS
    GRUBB, BP
    [J]. CHEST, 1990, 97 (05) : 1260 - 1260
12345